afamitresgene autoleucel
adaptimmune
['spearhead-1', 'adaptimmune']
we are grateful to our colleagues and collaborators working to "conquer cancer" and for people who are participating in the spearhead-1 #clinicaltrial. presented overall survival data today at #asco2023. 
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment